This topic contains a solution. Click here to go to the answer

Author Question: The F-test of the randomized block design of the analysis of variance has the same requirements as ... (Read 112 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
The F-test of the randomized block design of the analysis of variance has the same requirements as the independent samples design; that is, the random variable must be normally distributed and the population variances must be equal.
  Indicate whether the statement is true or false

Question 2

Assume that the control limits of an x chart are defined as 3 standard errors above and below the centerline. Calculate the probability that a sample mean falls outside the control limits when the process is in fact under control.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tennis14576

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

T

Answer to Question 2

P = P ( z  > 3) = P (z < -3) + P (z > 3) = 2(.50 - .4987) = .0026




bio_gurl

  • Member
  • Posts: 524
Reply 2 on: Jun 24, 2018
:D TYSM


vickybb89

  • Member
  • Posts: 347
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library